{"id":"W2621574813","doi":"10.1634/theoncologist.2016-0455","title":"Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis","year":2017,"lang":"en","type":"article","venue":"The Oncologist","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"European Society for Medical Oncology; Clalit Health Services; Burroughs Wellcome Fund","keywords":"Medicine; Bevacizumab; Colorectal cancer; Incremental cost-effectiveness ratio; Quality-adjusted life year; Cost effectiveness; Cost-effectiveness analysis; Willingness to pay; Cost–benefit analysis; Adverse effect; Oncology; Demography; Internal medicine; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007765788,0.00169072,0.0023276,0.003762238,0.0001775038,0.001501808,0.0007955187,0.001024066,0.003712448],"category_scores_gemma":[0.01448457,0.0005230875,0.007209207,0.003840192,0.0004403879,0.001337071,0.0009847705,0.001438533,0.0001850859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00463886,"about_ca_system_score_gemma":0.002304562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01261315,"about_ca_topic_score_gemma":0.009541109,"domain_scores_codex":[0.9967968,0.002361569,0.0001135959,0.0002021354,0.0003477905,0.0001780864],"domain_scores_gemma":[0.9955648,0.003569477,0.0003833625,0.00009868876,0.0002678832,0.0001158666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.005720311,0.0004620653,0.02990947,0.007830705,0.02835227,0.0007386283,0.0001322656,0.7772335,0.0006532624,0.01043557,0.01192876,0.1266032],"study_design_scores_gemma":[0.004959425,0.006615396,0.08007348,0.007252877,0.06224225,0.002572783,0.0007622996,0.7553046,0.001229281,0.04370765,0.03490258,0.0003773491],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.623951,0.2467828,0.05458478,0.01550032,0.0007755628,0.002477364,0.02442977,0.0003706486,0.03112774],"genre_scores_gemma":[0.9566902,0.0244741,0.01020073,0.00119207,0.000195299,0.0006056304,0.005719504,0.00006027597,0.0008623605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01261315,"threshold_uncertainty_score":0.04106987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0896050830222645,"score_gpt":0.4412394298392327,"score_spread":0.3516343468169682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}